MatthewStuartMcKinneyMD

PubMed

• Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North Am...
  Barr, P. M., Barr, P. M., Julie M Vose, Kai Fu, Lu Wang, Adnan Mansoor, Douglas Stewart, Hongxia Cheng, Lynette Smith, Ji Yuan, Hina Naushad Qureishi, Brian K Link, Me...> ;Journal of Hematology & Oncology. 2023 Dec 16
• 3 citations
  Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory follicular lymphoma (CITADEL-203): a phase 2 study.
  Marek Trněný, Abraham Avigdor, Matthew S McKinney, Shankara Paneesha, Björn E Wahlin, John S Hrom, David Cunningham, Nicholas Morley, Miguel Canales, Mariana Bastos-Or...> ;Eclinicalmedicine. 2023 Sep 1
• 1 citations
  Comparison of differing dose levels of methotrexate for patients with primary central nervous system lymphoma.
  Daniel P Schrum, Meredith T Moorman, Zhiguo Li, Mairead Dillon, Katherine B Peters, Matthew McKinney, Mallika P Patel> ;Journal of Oncology Pharmacy Practice. 2023 May 17
• Combinatorial Efficacy and Toxicity of an Engineered Toxin Body MT-3724 with Gemcitabine and Oxaliplatin in Relapsed or Refractory Diffuse Large B Cell Lymphoma.
  Chenyu Lin, Ahmed Galal, David Rizzieri, Sant Chawla, Seung T Lee, Angela Georgy, Kristina Dabovic, Thomas Strack, Matthew McKinney> ;Cancer Investigation. 2023 Jan 31
• 5 citations
  Implementation of a Molecular Tumor Registry to Support the Adoption of Precision Oncology Within an Academic Medical Center: The Duke University Experience.
  Michelle F. Green, Jonathan Bell, Christopher Hubbard, Shannon J. McCall, Matthew McKinney, Jinny E. Riedel, Carolyn S. Menendez, James L. Abbruzzese, John H. Strickle...> ;JCO Precision Oncology. 2021 Sep 16
• 3 citations
  Results and Clinical Utilization of Foundation Medicine Molecular Tumor Profiling in Uterine and Ovarian Cancers.
  Catherine H. Watson, Gloria Broadwater, Janice Wong, Daniel Spinosa, Mary Katherine Montes de Oca, Michael B. Datto, Michelle F. Green, Christopher Hubbard, Matthew Mc...> ;Targeted Oncology. 2021 Jan 1
• 6 citations
  Primary Mediastinal (Thymic) Large B-Cell Lymphoma: Fidelity of Diagnosis Using WHO Criteria
  Andrew T. Fairchild, Chad M. McCall, Taofik Oyekunle, Donna Niedzwiecki, Colin E. Champ, Matthew McKinney, Chris R. Kelsey> ;Clinical Lymphoma, Myeloma & Leukemia. 2021 May 1
• 84 citations
  Hodgkin lymphoma, version 2.2020
  Richard T. Hoppe, Ranjana H. Advani, Weiyun Z. Ai, Richard F. Ambinder, Philippe Armand, Celeste M. Bello, Cecil M. Benitez, Philip J. Bierman, Kirsten M Boughan, Bout...> ;Journal of the National Comprehensive Cancer Network. 2020 Jun 1
• 110 citations
  Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2
  Andrea B. Moffitt, Sarah L. Ondrejka, Matthew McKinney, Rachel E. Rempel, John R. Goodlad, Chun Huat Teh, Sirpa Leppä, Susanna Mannisto, Panu E. Kovanen, Eric Tse, Rex...> ;The Journal of Experimental Medicine. 2017 May 1
• 124 citations
  The Genetic Basis of Hepatosplenic T-cell Lymphoma
  Matthew McKinney, Andrea B. Moffitt, Philippe Gaulard, Marion Travert, Laurence de Leval, Alina Nicolae Mark Raffeld, Elaine S. Jaffe, Stefania Pittaluga, Liqiang Xi, ...> ;Cancer Discovery. 2017 Apr 1
• 183 citations
  Genomic landscape of cell-free DNA in patients with colorectal cancer
  John H. Strickler, Jonathan M. Loree, Leanne G. Ahronian, Aparna Raj Parikh, Donna Niedzwiecki, Allan Andresson Lima Pereira, Matthew McKinney, W. Michael Korn, Chloe ...> ;Cancer Discovery. 2017 Jan 1
• 5 citations
  Merkel cell carcinoma with partial B-cell blastic immunophenotype: a potential mimic of cutaneous richter transformation in a patient with chronic lymphocytic lymphoma.
  John A. Papalas, Matthew McKinney, Evan Kulbacki, Sandeep S. Dave, Endi Wang> ;The American Journal of Dermatopathology. 2014 Feb 1
• 42 citations
  PAK1 Mediates Resistance to PI3K Inhibition in Lymphomas
  Katherine Walsh, Matthew McKinney, Cassandra Love, Qingquan Liu, Alice Fan, Amee Patel, Jason L. Smith, Anne W. Beaven, Dereje D. Jima, Sandeep S. Dave> ;Clinical Cancer Research. 2013 Mar 1
• 423 citations
  The genetic landscape of mutations in Burkitt lymphoma
  , , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;Nature Genetics. 2012 Dec 1
• 9 citations
  Depleting regulatory T cells with arginine-rich, cell-penetrating, peptide-conjugated morpholino oligomer targeting FOXP3 inhibits regulatory T-cell function.
  Michael A. Morse, Amy Hobeika, Delila Serra, Katherine M. Aird, Matthew McKinney, Amy J. Aldrich, Timothy M. Clay, Dan V. Mourich, Herbert Kim Lyerly, Patrick L. Ivers...> ;Cancer Gene Therapy. 2012 Jan 1
• 18 citations
  Erythropoietin for oncology supportive care.
  Matthew McKinney, Murat O. Arcasoy> ;Experimental Cell Research. 2011 May 15
• 13 citations
  Induction of Wilms' tumor protein (WT1)-specific antitumor immunity using a truncated WT1-expressing adenovirus vaccine.
  Takuya Osada, Christopher Y. Woo, Matthew McKinney, Xiao Yi Yang, Gangjun Lei, Heather G. LaBreche, Zachary C. Hartman, Donna Niedzwiecki, Nelson J. Chao, Andrea Amalf...> ;Clinical Cancer Research. 2009 Apr 15
• Join now to see all

Abstracts/Posters

• A Phase 1 Study of ACTR087 in Combination with Rituximab, in Subjects with Relapsed or Refractory CD20-Positive B-Cell Lymphoma
  Matthew S. McKinney, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Whole Exome and Transcriptome Sequencing in 1042 Cases Reveals Distinct Clinically Relevant Genetic Subgroups of Follicular Lymphoma
  Matthew S. McKinney, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

• Novel Mechanisms for Resistance to Targeted Therapy Identified through Machine Learning Approaches in 1167 RNA-Seq Drug Exposure Profiles in Lymphoma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018